These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 18512311

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. CD7 is expressed on a subset of normal CD34-positive myeloid precursors.
    Kriegsmann K, Löffler H, Eckstein V, Schulz R, Kräker S, Braun U, Luft T, Hegenbart U, Schönland S, Dreger P, Krämer A, Ho AD, Müller-Tidow C, Hundemer M.
    Eur J Haematol; 2018 Sep; 101(3):318-325. PubMed ID: 29797671
    [Abstract] [Full Text] [Related]

  • 23. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
    van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S, van der Pol MA, Waisfisz Q, Ossenkoppele GJ, Schuurhuis GJ.
    Clin Cancer Res; 2005 Sep 15; 11(18):6520-7. PubMed ID: 16166428
    [Abstract] [Full Text] [Related]

  • 24. [Relationship of immunophenotypic features with minimal residual disease detection and gene types in 221 cases of acute promyelocytic leukemia].
    Wang YZ, Qin YZ, Jiang B, Zhu HH, Chang Y, Hao L, Li JL, Li LD, Chen SS, Huang XJ, Liu YR.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr 15; 17(2):271-6. PubMed ID: 19379549
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Zhang X, Wu Y, Li C, Shen K, Li R.
    Clin Lab; 2023 Jun 01; 69(6):. PubMed ID: 37307129
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A, Gillis D, Hissaria P, Lewis I.
    Am J Clin Pathol; 2008 Jun 01; 129(6):934-45. PubMed ID: 18480011
    [Abstract] [Full Text] [Related]

  • 30. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
    Xie W, Wang X, Du W, Liu W, Qin X, Huang S.
    Cytometry A; 2010 Sep 01; 77(9):840-8. PubMed ID: 20662087
    [Abstract] [Full Text] [Related]

  • 31. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T, Kimura N, Sawada H, Suematsu E, Nagano M, Akiyoshi T, Motomura S, Kikuchi M, Nishimura J, Tamura K.
    Intern Med; 1999 Jul 01; 38(7):547-55. PubMed ID: 10435360
    [Abstract] [Full Text] [Related]

  • 32. N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia.
    Coustan-Smith E, Behm FG, Hurwitz CA, Rivera GK, Campana D.
    Leukemia; 1993 Jun 01; 7(6):853-8. PubMed ID: 7684798
    [Abstract] [Full Text] [Related]

  • 33. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
    Xu B, Hu C, Miao XD, Wu YH, Yi ZS, Yang Y, Meng FY, Feng R, Liu QF, Liu XL, Zheng WY.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct 01; 23(10):1043-6. PubMed ID: 14559689
    [Abstract] [Full Text] [Related]

  • 34. Leukemia-associated immunophenotypes subdivided in "categories of specificity" improve the sensitivity of minimal residual disease in predicting relapse in acute myeloid leukemia.
    Rossi G, Giambra V, Minervini MM, De Waure C, Mancinelli S, Ciavarella M, Sinisi NP, Scalzulli PR, Carella AM, Cascavilla N.
    Cytometry B Clin Cytom; 2020 May 01; 98(3):216-225. PubMed ID: 31697027
    [Abstract] [Full Text] [Related]

  • 35. Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia.
    Zeijlemaker W, Kelder A, Cloos J, Schuurhuis GJ.
    Curr Protoc Cytom; 2019 Dec 01; 91(1):e66. PubMed ID: 31763792
    [Abstract] [Full Text] [Related]

  • 36. Flow cytometric analysis of CD34+ CD38- cells; cell frequency and immunophenotype based on CD45RA expression pattern.
    Mizuta S, Iwasaki M, Bandai N, Yoshida S, Watanabe A, Takashima H, Ueshimo T, Bandai K, Fujiwara K, Hiranuma N, Koba Y, Kawata T, Tamekane A, Watanabe M.
    Cytometry B Clin Cytom; 2024 Jan 01; 106(1):35-44. PubMed ID: 37933409
    [Abstract] [Full Text] [Related]

  • 37. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
    Haase D, Feuring-Buske M, Schäfer C, Schoch C, Troff C, Gahn B, Hiddemann W, Wörmann B.
    Leukemia; 1997 May 01; 11(5):674-9. PubMed ID: 9180291
    [Abstract] [Full Text] [Related]

  • 38. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
    de Figueiredo-Pontes LL, Pintão MC, Oliveira LC, Dalmazzo LF, Jácomo RH, Garcia AB, Falcão RP, Rego EM.
    Cytometry B Clin Cytom; 2008 May 01; 74(3):163-8. PubMed ID: 18200595
    [Abstract] [Full Text] [Related]

  • 39. Universal monitoring of minimal residual disease in acute myeloid leukemia.
    Coustan-Smith E, Song G, Shurtleff S, Yeoh AE, Chng WJ, Chen SP, Rubnitz JE, Pui CH, Downing JR, Campana D.
    JCI Insight; 2018 May 03; 3(9):. PubMed ID: 29720577
    [Abstract] [Full Text] [Related]

  • 40. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
    Chávez-González A, Dorantes-Acosta E, Moreno-Lorenzana D, Alvarado-Moreno A, Arriaga-Pizano L, Mayani H.
    Arch Med Res; 2014 May 03; 45(4):343-50. PubMed ID: 24751333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.